BioCentury
ARTICLE | Clinical News

Xanomeline plus trospium chloride: Phase I started

September 26, 2016 7:00 AM UTC

Karuna began a double-blind, placebo-controlled, U.S. Phase I trial to compare 75 mg oral xanomeline thrice daily plus 20 mg oral trospium chloride twice daily for 7 days vs. xanomeline alone in up to...